ArrowMark Colorado Holdings LLC Has $8.93 Million Holdings in Tenet Healthcare Co. (NYSE:THC)

ArrowMark Colorado Holdings LLC cut its stake in shares of Tenet Healthcare Co. (NYSE:THC - Free Report) by 29.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 70,766 shares of the company's stock after selling 29,091 shares during the period. ArrowMark Colorado Holdings LLC owned 0.07% of Tenet Healthcare worth $8,933,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Geode Capital Management LLC increased its holdings in Tenet Healthcare by 3.5% during the 4th quarter. Geode Capital Management LLC now owns 2,116,121 shares of the company's stock worth $268,591,000 after purchasing an additional 71,454 shares during the last quarter. Norges Bank acquired a new position in shares of Tenet Healthcare during the fourth quarter valued at $190,819,000. Dimensional Fund Advisors LP increased its position in shares of Tenet Healthcare by 22.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,493,532 shares of the company's stock valued at $188,524,000 after purchasing an additional 272,906 shares during the period. AQR Capital Management LLC grew its holdings in shares of Tenet Healthcare by 20.8% in the 4th quarter. AQR Capital Management LLC now owns 872,117 shares of the company's stock worth $110,087,000 after acquiring an additional 150,361 shares during the last quarter. Finally, Northern Trust Corp grew its position in Tenet Healthcare by 22.0% during the 4th quarter. Northern Trust Corp now owns 848,049 shares of the company's stock worth $107,049,000 after purchasing an additional 152,671 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company's stock.

Insider Buying and Selling at Tenet Healthcare

In other news, Director J Robert Kerrey sold 9,525 shares of the stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the sale, the director now owns 27,378 shares of the company's stock, valued at $3,434,022.54. This represents a 25.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.81% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on THC shares. Baird R W cut Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. The Goldman Sachs Group increased their price objective on Tenet Healthcare from $134.00 to $154.00 and gave the company a "neutral" rating in a research report on Monday. Cantor Fitzgerald reiterated an "overweight" rating and issued a $177.00 target price on shares of Tenet Healthcare in a report on Thursday, February 13th. Morgan Stanley raised their price objective on Tenet Healthcare from $165.00 to $175.00 and gave the company an "overweight" rating in a report on Monday. Finally, StockNews.com raised Tenet Healthcare from a "hold" rating to a "buy" rating in a report on Thursday, May 1st. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to data from MarketBeat, Tenet Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $173.69.

Tenet Healthcare Price Performance

Shares of Tenet Healthcare stock traded up $0.68 on Wednesday, hitting $152.16. 1,244,286 shares of the company were exchanged, compared to its average volume of 1,551,921. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. The company has a 50-day moving average price of $127.86 and a 200 day moving average price of $136.11. Tenet Healthcare Co. has a 1-year low of $109.82 and a 1-year high of $171.20. The stock has a market capitalization of $14.13 billion, a price-to-earnings ratio of 4.72, a price-to-earnings-growth ratio of 1.02 and a beta of 1.63.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, topping the consensus estimate of $3.11 by $1.25. The business had revenue of $5.22 billion during the quarter, compared to the consensus estimate of $5.15 billion. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The company's quarterly revenue was down 2.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.22 earnings per share. As a group, sell-side analysts predict that Tenet Healthcare Co. will post 12.24 earnings per share for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.